DrugPatentWatch Database Preview
Details for Patent: 7,316,067
Which drugs does patent 7,316,067 protect, and when does it expire?
Patent 7,316,067 protects LONHALA MAGNAIR KIT and is included in one NDA.
This patent has six patent family members in four countries.
Summary for Patent: 7,316,067
| Title: | Forming a perforate membrane by laser drilling and a subsequent electro-polishing step |
| Abstract: | A method of forming a perforate membrane (1) is disclosed for use in a liquid transport device. The membrane has at least plural nozzles (10) formed therethrough. Each of those nozzles has a throat portion (12) opening at opposite end through opposite surface (2') of the perforate membrane and a smoothly curved outwardly diverging portion (11) extending from the first end of the throat portion to the first surface (2) of the perforate membrane. Laser energy is applied selectively to the first surface (2) of the membrane in the form of a pulsed, focused beam to form the nozzles (10) and thereafter the first surface (2) of the membrane and the surface of the diverging portion (11) of the nozzles (10) are electro-polished to remove surface imperfections. The electro-polishing is controlled so as to remove material from the surface of the diverging portion (11) of the nozzles to a depth less than the length of the throat portion (12). |
| Inventor(s): | Blakey; David Mark (Herts, GB) |
| Assignee: | The Technology Partnership (Melbourn Royston, Hertz, GB) |
| Application Number: | 10/489,327 |
|
Patent Claim Types: see list of patent claims | Use; Device; |
Drugs Protected by US Patent 7,316,067
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sunovion Resp | LONHALA MAGNAIR KIT | glycopyrrolate | SOLUTION;INHALATION | 208437-001 | Dec 5, 2017 | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 7,316,067
| Foriegn Application Priority Data | ||
| Foreign Country | Foreign Patent Number | Foreign Patent Date |
| 01308106 | Sep 24, 2001 | |
| PCT Information | |||
| PCT Filed | September 06, 2002 | PCT Application Number: | PCT/GB02/04093 |
| PCT Publication Date: | April 03, 2003 | PCT Publication Number: | WO03/026832 |
International Family Members for US Patent 7,316,067
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Germany | 60231995 | Start Trial | |||
| European Patent Office | 1295647 | Start Trial | |||
| European Patent Office | 1429888 | Start Trial | |||
| Japan | 2005503266 | Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
